Health Care • Biotechnology: Laboratory Analytical Instruments
$57.07 ▼ -4.93
(-7.95%)
MKT CAP: $9.45B • VOL: 1.92M
52W L $32 52W H $67
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$48
MEDIAN
$64
MEAN
$65
HIGH
$78
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BRKR TAPE
BRKR // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $69.05 | $65.63 | 2025-02-14 | $51.93 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $71.91 | $67.34 | 2025-02-06 | $53.65 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $65.06 | $62.78 | 2025-01-29 | $54.79 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $58.21 | — | 2025-01-17 | $55.93 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $50.22 | $54.22 | 2025-01-09 | $50.79 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $67.91 | $59.35 | 2024-12-18 | $49.65 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $55.36 | $57.64 | 2024-12-04 | $53.08 | -4.3% | 48% | C |